The future of immunotherapy. Report of a National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation (DAIT) workshop

Abstract

Recent advances in the molecular sciences make possible new and innovative immunotherapeutic approaches to the treatment of human asthma and allergic disorders. In 2005, the National Institute of Allergy and Infectious Diseases, Division of Allergy, Immunology and Transplantation, sponsored a workshop entitled Immunological Basis of Antigen-specific Asthma/Allergies Therapeutic Strategies Meeting. International experts in the field of asthma and allergy immunotherapy discussed the current state of immunotherapy, and made recommendations for future areas of research aimed at advancing our knowledge and understanding of immunotherapy for asthma and allergic diseases. The workshop recommendations are presented herein. © 2006 Blackwell Munksgaard.